Profile
| Metric | Value |
|---|---|
| Full Name | IQVIA Holdings Inc. |
| Ticker | NYSE: IQV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | iqvia.com |
| Employees | 90,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $243.19 | |
| Price, 1D Change | -0.45% | |
| Market Cap | $41B | |
| - | ||
| PE Ratio | 33.39 | |
| Beta | 1.02 | |
| Revenue | $15B | |
| Revenue, 1Y Change | +2.95% | |
| EPS | $7.49 | |
| EPS, 1Y Change | +2.70% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | Q | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $7.49 | |
| EPS Estimate | $11.89 | |
| EPS Est. Change | +58.85% | |
| Revenue | $15.41B | |
| Revenue Estimate | $16.19B | |
| Revenue Est. Change | +5.09% | |
| Current Price | $243.19 | |
| Price Target | - | $255.50 |
| Price Tgt. Change | - | +5.06% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $10.19 | $7.29 | -28.47% | |
| $11.12 | $7.49 | -32.65% | |
| $11.89 | N/A | +58.85% | |
| $12.94 | N/A | +72.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.91B | $14.96B | +0.34% | |
| $15.38B | $15.41B | +0.17% | |
| $16.19B | N/A | +5.09% | |
| $17.07B | N/A | +10.78% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +19.02% | |
| Price, 3Y | +18.42% | |
| Market Cap, 1Y | +15.10% | |
| Market Cap, 3Y | +8.60% | |
| Revenue, 1Y | +2.95% | |
| Revenue, 3Y | +11.00% | |
| EPS, 1Y | +2.70% | |
| EPS, 3Y | +51.12% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $243.19 | |
| SMA 200 | $184.89 | |
| SMA 200 vs Price | -23.97% | |
| SMA 50 | $223.24 | |
| SMA 50 vs Price | -8.20% | |
| Beta | 1.02 | |
| ATR | $5.24 | |
| 14-Day RSI | 72.95 | |
| 10-Day Volatility | 24.28% | |
| 1-Year Volatility | 38.46% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $15.41B | |
| EPS | $7.49 | |
| Gross Profit | $5.38B | |
| Gross Margin | 34.89% | |
| Operating Profit | $2.27B | |
| Operating Margin | 14.73% | |
| Net Income | $1.37B | |
| Net Margin | 8.91% | |
| EBITDA | $3.45B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.39 | |
| Current Ratio | 0.84 | |
| Quick Ratio | 0.84 | |
| Interest Coverage | 3.49 | |
| F-Score | 5 | |
| Altman Z-Score | 2.32 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 33.39 | |
| PS Ratio | 2.60 | |
| PB Ratio | 6.72 | |
| EV/EBITDA | 16.13 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $6.07B | |
| Cash & Equivalents | $1.84B | |
| Total Assets | $26.90B | |
| Current Assets | $5.83B | |
| Total Liabilities | $20.83B | |
| Current Liabilities | $6.96B | |
| Total Debt | $14.48B | |
| Short Term Debt | $1.25B | |
| Accounts Payable | $736.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $13.14B | |
| Operating Expenses | $3.11B | |
| Cost Of Goods Sold | $10.03B | |
| SG&A | $1.99B | |
| D&A | $1.11B | |
| Interest Expense | $670.00M | |
| Income Tax | $301.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $2.72B | |
| CFI | -$1.44B | |
| CFF | -$878.00M | |
| Capex | $602.00M | |
| Free Cash Flow | $2.11B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | → | |
| BMO Capital | ||
| TD Cowen | → | |
| UBS | → | |
| Truist Securities | → | |
| Stifel | → | |
| JP Morgan | → | |
| Citigroup | → | |
| Baird | → | |
| HSBC | → |
Analyst sentiment
Institutional ownership
Screeners with IQV
Data Sources & References
- IQV Official Website www.iqvia.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1478242/000162828025046794/0001628280-25-046794-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1478242/000147824225000045/0001478242-25-000045-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- IQV Profile on Yahoo Finance finance.yahoo.com/quote/IQV
- IQV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iqv
FAQ
What is the ticker symbol for IQVIA Holdings Inc.?
The ticker symbol for IQVIA Holdings Inc. is NYSE:IQV
Does IQVIA Holdings Inc. pay dividends?
No, IQVIA Holdings Inc. does not pay dividends
What sector is IQVIA Holdings Inc. in?
IQVIA Holdings Inc. is in the Healthcare sector
What industry is IQVIA Holdings Inc. in?
IQVIA Holdings Inc. is in the Diagnostics & Research industry
What country is IQVIA Holdings Inc. based in?
IQVIA Holdings Inc. is headquartered in United States
When did IQVIA Holdings Inc. go public?
IQVIA Holdings Inc. initial public offering (IPO) was on May 9, 2013
Is IQVIA Holdings Inc. in the S&P 500?
Yes, IQVIA Holdings Inc. is included in the S&P 500 index
Is IQVIA Holdings Inc. in the NASDAQ 100?
No, IQVIA Holdings Inc. is not included in the NASDAQ 100 index
Is IQVIA Holdings Inc. in the Dow Jones?
No, IQVIA Holdings Inc. is not included in the Dow Jones index
When was IQVIA Holdings Inc. last earnings report?
IQVIA Holdings Inc.'s most recent earnings report was on October 28, 2025
When does IQVIA Holdings Inc. report earnings?
The next expected earnings date for IQVIA Holdings Inc. is February 5, 2026